[Thymidine kinase as a biological marker in neoplasms of the lung and mediastinum]
Related Experiment Video
Updated: Oct 1, 2026

Immunofluorescent Detection of Two Thymidine Analogues (CldU and IdU) in Primary Tissue
Published on: December 8, 2010
F De Blasio1, M Alonzo, S Zofra
1II Facoltà di Medicina e Chirurgia, Cattedra di Malattie dell'Apparato Respiratorio, Università degli Studi di Napoli.
Abstract:
Thymidine kinase (TK) is a biological marker recently used in diagnosis and monitoring of pulmonary and mediastinal malignant neoplasms. Authors report more recent clinical evidences of literature and, in the meanwhile, they report their personal experiences about a 20 patients group suffering of lung cancer and Hodgkin disease. Their study demonstrates a good sensitivity of TK as biological marker of SCLC and a lower sensitivity in case of NSCLC and Hodgkin disease. It has been possible to contribute to establishment of normal range values, on account of 10 healthy volunteer group blood sample assays.

